Table 3 Comparison of IHC results for ER, PGR, and Her2 with respective RT2-Profiler RNA expression values and Oncotype DX singe gene scores.
patient | ER Score (GHI) | ER IHC [% pos. cells] | unrestricted Ct-value | PR Score (GHI) | PGR IHC [% pos. cells] | unrestricted Ct-value | Her2 Score (GHI) | Her2 IHC [% pos. cells] | unrestricted Ct-value |
---|---|---|---|---|---|---|---|---|---|
1 | + | 100 | + | − | 2 | − | − | 1 | − |
2 | + | 80 | − | + | 30 | − | − | 1 | − |
3 | + | 100 | + | − | 100 | + | − | 1 | + |
5 | + | 100 | + | + | 100 | + | − | 30 | − |
6 | + | 90 | + | + | 0 | + | − | 30 | + |
7 | + | 98 | − | + | 95 | + | − | 1 | − |
8 | + | 100 | − | − | 100 | − | − | 40 | − |
10 | + | 90 | − | + | 70 | − | − | 1 | − |
11 | + | 100 | + | + | 100 | + | − | 1 | + |
12 | + | 90 | + | + | 80 | + | − | 1 | + |
14 | + | 100 | + | + | 100 | + | − | 15 | + |
15 | + | 100 | − | − | 100 | − | − | 1 | − |
16 | + | 60 | + | + | 80 | + | − | 30 | + |
17 | + | 100 | + | + | 100 | − | − | 30 | + |
19 | + | 95 | + | + | 70 | + | − | 30 | + |
20 | + | 100 | + | + | 100 | + | − | 40 | + |
21 | + | 100 | − | + | 95 | − | − | 1 | − |
22 | + | 100 | + | + | 100 | + | − | 40 | + |
23 | + | 90 | + | − | 1 | + | * | 40 | + |
24 | + | 80 | − | + | 80 | − | − | 1 | − |
25 | + | 95 | + | + | 40 | + | − | 40 | + |
26 | + | 100 | + | + | 100 | + | − | 1 | − |
27 | + | 100 | − | + | 70 | + | − | 40 | − |
28 | + | 90 | + | + | 80 | + | − | 1 | + |
29 | + | 70 | + | + | 40 | + | − | 40 | + |
30 | + | 100 | + | + | 95 | + | − | 30 | + |
31 | + | 90 | − | + | 40 | − | − | 30 | − |
32 | + | 100 | + | + | 85 | + | − | 10 | + |
I | + | 60 | + | − | 75 | − | − | 10 | + |
II | + | 90 | + | + | 45 | − | − | 10 | − |
III | + | 90 | + | + | 90 | + | − | 10 | + |
IV | + | 90 | + | + | 60 | + | − | 30 | + |